, while the non-TLR response is mediated through two cytosolic nucleic acid sensors (RIG-I in humans 8 and DAI in mouse 9 ). HSV possesses several molecular components capable of activating an innate response: 1) HSV DNA: either through TLR9-dependent recognition of unmethylated CpG motifs 10 or non-TLR DNA sensors 11 ; 2) glycoproteins recognized by TLR2 4, 5 ; and 3) dsRNA generated through self-hybridization of viral genes transcribed from complementary DNA strands 12, 13 . The multiplicity of pattern recognition receptors (PRR) detecting HSV necessitates a robust ability of the virus to effectively block multiple innate signaling pathways in order to survive.
Previous studies identified several HSV-encoded mechanisms that interfere with anti-viral host immunity including non-specific degradation of host mRNA by the RNAse VHS 14 , inhibition of PKR by US11 15 and γ34.5 16 , inhibition of MHC-I peptide loading by ICP47 17, 18 and suppression of interferon response by ICP0 19, 20 . However, to date, no HSV encoded protein has been shown to interfere with TLR responses. Our previous studies comparing two versions of the HSV amplicon vector, helper-virus containing HSV amplicon (H+-HSV) and helper-virus free HSV amplicon (HF-HSV), in primary chronic lymphocytic leukemia (CLL) B cells identified an immunosuppressive activity associated with the HSV helper virus, which appeared to inhibit development of anti-tumor T cell immunity 21 . In contrast helper-free HSV amplicon (HF-HSV) possessed an adjuvant immunostimulatory effect that translated into potent anti-CLL response. An understanding of how specific components of HSV activate and/or inhibit innate immunity would allow for rational design of gene therapy vectors specifically tailored for particular clinical applications. HSV amplicon vectors only.
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Through systematic comparison of innate response elicited by H+-HSV and HF-HSV amplicons, we identified the HSV immediate early (IE) protein ICP0 as an inhibitor of TLR-mediated NF-κB response. ICP0 inhibitory activity is dependent on its association with the USP7 (HAUSP) and requires an intact nuclear localization signal (nls) motif. USP7 downregulates TLR-mediated NF-κB-dependent inflammatory cytokine/ chemokine response through de-ubiquitination of TRAF6 and IKKγ. Our results show that USP7 serves a regulatory function in TLR response and this function is usurped by HSV ICP0 to suppress host innate response in HSV-infected cells.
only.
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Materials and methods
Cells lines, plasmids, antibodies and reagents: CLL B cells, obtained from patients with confirmed diagnosis of CLL after informed consent was given in accordance with the Declaration of Helsinki and with approval of the University of Miami, were isolated by density gradient centrifugation over endotoxin-free Lymphoprep (Nycomed pharma, Oslo, Norway). HEK293 cells stably transfected with human TLRs were purchased from InvivoGen, cultured in DMEM plus 5 % FCS under selection with blasticidin (10 µg/ml). Genomic HSV-1 DNA was extracted from HSV virus using QIAamp DNA mini kit, and used at final concentration of 0.5 μg/ml. HSV ICP0 and its mutants (M4, FXE), USP7 and USP7.C223S were kindly provided by Dr. R. Everett [22] [23] [24] . ICP0.NLS mut was generated by sitedirected mutagenesis of wt-ICP0 NLS motif 500-VRPRKRR-506 into 500-VRPAARA-506. USP7.NES was generated by introducing nuclear export signal (NES) (LPPLERLTL) from HIV-I Rev protein inframe between the Ds-Red tag and USP7 in pDs.Red2-USP7 (Clontech). Full-length HSV ICP22, ICP27 and ICP47 were cloned into pIRES-hrGFPII (Stratagene). P3X.FLAG-TRAF6 and IKKγ were generated by cloning human TRAF6/IKKγ into p3X.FLAG-CMV-26 (Sigma-Aldrich).
Cyclohexamide (CHX) and MG-132 were purchased from Sigma-Aldrich Antibodies: FLAG-tagged proteins (ICP22, ICP27, ICP47, TRAF6 and IKKγ) were detected using anti-FLAG M2 antibody (Sigma-Aldrich). ICP0 and USP7 were detected using mouse anti-ICP0 (H1A027-100) (Virusys Corporation) and rabbit anti-USP7 (A300-033A) (Bethyl), respectively. Anti-HA antibody (12CA5) was purchased from Roche Applied Science. Anti-JNK (56G8), phospho-JNK (9251), Iκ-Bα (44D4), phospho-Iκ-Bα (5A5), NF-κB p65 (3034), α/β tubulin (2148) antibodies were purchased from Cell Signal. Anti-TRAF6, anti-IKKγ antibodies were purchased from Santa-Cruz biotechnology.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 6 HSV Amplicon Viruses: Coding sequence for a modified version of E coli β-galactosidase in which CpG sequences were mutated (Invivogen) were cloned into the polylinker region of the pHSVPrPUC plasmid and packaged into either Helper-virus containing (H + -HSV) 25 or helper-virus free (HF-HSV) amplicon stocks as previously described 26 . Amplicon titers were determined using a previously published methodology 27 .
RNA isolation and real-time PCR: RNA was isolated using RNeasy Mini Kits (QIAGEN Inc), cDNA was synthesized using a mix of oligo dT, random hexamer (Ambion) and SuperScript RT-III reverse transcriptase (Invitrogen Corp.) Quantitative real-time PCR was performed on an Applied
Biosystems ABI Prism 7900HT using Applied Bio-systems Taqman Gene Expression Assays, and normalized to the housekeeper PGK-1 as follows:
Relative expression was calculated using the formula: 2 -∆∆CT and expressed as arbitrary units.
Transient transfection and reporter gene analysis:
For NF-κB reporter assays, we used pNiFty2-Luc (Invivogen). A constitutively active Renilla luciferase plasmid, pRLTK (0.02 µg per transfection) was used to normalize for transfection efficiency (Promega).
RNAi: 293-TLR4 cells were transfected with either non-targeting shRNA or shRNA specific for USP7, Cyld or A20 (Open Biosystems) using Lipofectamine LTX (Invitrogen) and 24 hours later selected under Puromycin (1 μg/ml). 48 hours later, the cells were transfected with pCI-ICP0 vs.
empty vector (pCI-Neo) together with pNF-κB-Luc reporter construct and 24 hours later, stimulated by LPS for 4 hours before luciferase activity was assayed qRT-PCR for IL8 and TNF-α.
Confocal Microscopy: 293T or 293-TLR4 cells were seeded onto 20-mm cover-slips on a 6-well plate and transfected with the indicated plasmids. 36 hours later, the cells were washed with PBS and stained with ProLong anti-fade mounting reagent (Molecular Probes). Images were acquired using only.
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Tandem-affinity purification:
The cDNA for human USP7 was cloned into the mammalian expression vector pcDNA™3.2/capTEV™-CT/V5-DEST using Gateway technology (Invitrogen), and Tandem-affinity purification performed according to manufacturer's instructions Briefly, pcDNA™3.2/capTEV™-CT/V5-USP7 was expressed in 293-TLR4 and 24 hours later, the cells were split and one half stimulated with LPS for 1 hour. Cells were lysed in Lysis buffer (100 mM Tris-HCl pH 8.0, 100 mM KCl, 200 μ M EDTA, 1.5 mM MgCl2, 1X (700 ng/ml) Pepstatin, complete protease inhibitor (Roche) by freeze-thaw x 3. The cleared lysate were incubated with streptavidin-agarose for 4 hours at +4°C before being washed and USP7 was cleaved off column by AcTEV protease overnight at +4°C, concentrated and IPed on Nickel-affinity column and the eluate was resolved on SDS-PAGE and blotted with anti-USP7, TRAF6 and IKKγ. IP/nuclear:cytoplasmic fractionation: 293T cells transfected with the indicated plasmids for 48 hours, were lysed in radioimmuno-precipitation assay (RIPA) buffer supplemented with the protease inhibitor cocktail (SigmaFAST, Sigma-Aldrich) and immuno-precipitated using anti-FLAG beads (Sigma-Aldrich, St Louis, MO). The agarose beads were washed three times with RIPA buffer supplemented with 1 M urea. Endogenous TRAF6/IKKγ were IPed using specific Abs (Santa Cruz biotechnology) and protein G agarose (Invitrogen). EMSA: Nuclear extracts from THP-1 cells were prepared as described above. Biotin 3`-end-labeled DNA duplex, as well as unlabelled duplex, of the NF-κB putative consensus binding motif 5'-AGT TGA GGG GAC TTT CCC AGG C-3 and 3'-TCA ACT CCC CTG AAA GGG TCC G-5' were purchased from IDT-DNA. 5 µg of nuclear extract protein were incubated with 2 nM biotin-labeled probe in binding buffer as previously described 28 .
De-ubiquitination Assays
293T cells were transfected with HA-ubiquitin, 3X-FLAG-TRAF6 or IKKγ vectors (pCMV-3X.FLAG-26, Sigma) and the indicated plasmids. 36 hrs later, cells were lysed in RIPA buffer supplemented with protease inhibitor cocktail, 20 μM of the ubiquitin hydrolase inhibitor Nethylmaleimide (NEM) (Sigma-aldrich), then boiled in 1% SDS for 5 minutes to remove noncovalently bound proteins. The cell lysates were then immuno-precipitated over-night at 4 °C using anti-FLAG beads (Sigma-Aldrich). The agarose beads were washed three times with RIPA buffer followed by elution with 3X FLAG peptide (Sigma-aldrich). The eluted HA-ubiquitin-conjugated TRAF6 and IKKγ were blotted using mouse polyclonal anti-HA (clone 12CA5, Roche applied Science) and detected using anti-mouse TrueBlot WB kit (eBioscience).
Statistical analysis: Data were analyzed using one-way ANOVA and results expressed as mean + 
ICP0 encoded by the Helper virus inhibits innate responses to HSV infection:
To 
ICP0 inhibition of the TLR-mediated-NF-κB response is dependent on its association with the de-ubiquitinating enzyme USP7:
ICP0 is a multi-domain protein that mediates proteasomal degradation of a number of cellular only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 13 proteins (PML, SP-100, DNA-PK and CD83) through its N-terminus RING domain E3 ligase function. The latter also inhibits innate response to HSV infection in part through interference with IRF3/IRF7-mediated transcription of ISRE-responsive genes and degradation of IRF3 20, 33 . ICP0 contains a nuclear localization signal (nls) (aa 500-506) 34 that enables it to translocate from cytosol to nucleus and also a USP7 (HAUSP) binding motif (aa 618-638) 22 . To identify the underlying mechanism(s) by which ICP0 inhibits the TLR response, we compared a series of ICP0 mutants RING domain (ICP0-FXE) compromised ICP0 ability to inhibit IRF3-dependent response as previously reported 35 , but had modest effect on its capacity to inhibit NF-κB-dependent cytokine response. Mutation of ICP0 nls motif (ICP0-NLS-MUT ) compromised its capacity to inhibit both NF-κB and IRF3-dependent pathways. These results suggest that ICP0 inhibition of TLR-induced NF-κB response is mediated through its association with the de-ubiquitinating (DUB) enzyme USP7
(HAUSP) and requires ICP0 to shuttle to the nucleus where USP7 is expressed. Since USP7 is a nuclear protein, it is conceivable that the inability of ICP0.NLS-MUT to inhibit NF-κB-dependent cytokine response might be secondary to its inability to gain access to nuclear USP7.
ICP0 alters cellular localization of USP7:
TLR signaling initiates at the cell membrane (TLR1, 2, 4, 5 and 6) or within acidic endosomes (TLR3, 7, 8 and 9) and proceeds to liberate NF-κB subunits from I-κB. ICP0 shuttles between the nucleus and cytoplasm while USP7 is a nuclear protein that resides within specialized nuclear structures known as PML or ND10 36 . This suggested to us that ICP0 might inhibit TLR signaling by facilitating the export only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From of USP7 from the nucleus to the cytoplasm. To address this question, we studied the sub-cellular localization of USP7 in the presence and absence of ICP0 and in response to TLR engagement. As shown in figure 4 .A, panel I, wt-ICP0 is detectable both within the nucleus and cytoplasm. Mutations within the NLS sequence (ICP0-NLS-MUT ) excluded ICP0 from the nucleus (panel II) and precluded its interaction with nuclear USP7 (panel VI). USP7, which appeared as a nuclear protein in the absence of ICP0 (panel III) translocated to a peri-nuclear compartment when co-expressed with wt-ICP0 (panel V). In agreement with previous studies showing that USP7 undergoes proteasomal degradation by ICP0 37 , we detected reduced levels of USP7 in cells co-expressing wt-ICP0 (panel V). ICP0-NLS-MUT failed to alter USP7 localization. Modifying USP7 to encode a nuclear export signal, USP7 NES allowed a fraction of USP7 to be detected within the cytoplasm in the absence of ICP0 (panel IV). Since ICP0-
NLS-
MUT failed to inhibit the TLR response, this suggested that translocating USP7 from its nuclear to cytoplasmic location might be a key element in ICP0 inhibition of TLR response.
To assess physiologic relevance of USP7 localization in the context of TLR signaling, we studied whether TLR stimulation induced nuclear export of USP7 independent of HSV. 293-TLR4 cells were LPS-stimulated and cellular localization of fluorescent USP7 was traced over 1 hour. As shown in figure 4 .B, TLR stimulation induced USP7 translocation to the cytoplasm as early as 20 minutes following LPS stimulation and this effect was maintained for up to 1 hour. These results were confirmed by biochemical fractionation of LPS-stimulated 293-TLR4 (figure 5.A) and THP1 stimulated with either LPS or CpG ODN ( Figure 5 .B). This data represents the first such example linking USP7 to TLR response and would suggest that HSV ICP0 exploits USP7 to suppress host innate response.
USP7 knock-down augments the TLR-mediated NF-κB response:
For
org From
To investigate whether endogenous USP7 played a regulatory role similar to that of A20 and Cyld, two other de-ubiquitinating (DUB) enzymes capable of suppressing NF-κB activity, we compared cytokine/chemokine response of LPS-stimulated HEK293-TLR4 transfected with shRNA targeting USP7, A20 or Cyld. Knock-down of USP7 enhanced innate response in a manner comparable to that seen in A20-and Cyld-depleted cells ( figure 5.C) . Similar results were obtained using 293-TLR2/6 (supplementary data S3) On the other hand, over-expression of USP7 inhibited NF-κB reporter response to HEK293-TLR2/6, TLR9 stimulation and MyD88 over-expression (supplementary data S4).
USP7 encodes an 1102 amino acid nuclear protein with a TRAF-like domain (T.D) at the NH2-terminus 38 , ubiquitin-specific protease domain (USP) catalytic center (208 -560) 39 and ICP0 binding domain between (aa 622-801) 40 . Experiments comparing full length USP7 (F. 
USP7 binds and de-ubiquitinates TRAF6 and IKKγ:
USP7 possesses a TRAF-like domain at the N-terminus of the protein (aa that has been previously shown to interact with TRAF6 in vitro 38 . Crystallographic studies of USP7 TRAF-like domain in conjunction with peptides derived from two of its substrates, MDM2 and p53, identified the sequence P/AXXS as a consensus binding motif within USP7 substrates 41 , a similar motif, EXXS was found within the EBNA1 peptide binding USP7 42 . We scanned TRAF6 and IKKγ, two components of the TLR signaling pathway that undergo stimulus-induced K63-ubiquitination, and are substrates for only.
For Previous studies showed that the ubiquitin-editing enzyme A20 terminates TNF-α receptor signaling by cleaving K63-linked poly-ubiquitin chains off RIP-1, mediated by its N-terminus OTUdomain, followed by K48-poly-ubiquitination and proteasomal degradation of RIP1 mediated by its Cterminus E3 ligase zinc-finger 44 . Given the capacity of ICP0 to poly-ubiquitinate various substrates for proteasomal degradation through its N-terminus RING E3 ligase function, we questioned whether ICP0/USP7 could function in tandem to mimic the effect of A20, with USP7 de-ubiquitinating TRAF6/IKKγ followed by ICP0-mediated K48-poly-ubiquitination and degradation. To address this issue, TRAF6 and IKKγ were individually co-expressed with different concentrations of ICP0 in the presence or absence of the proteasome inhibitor MG-132 and protein levels were assessed by WB. As Figure 7 .F illustrates, there was no evidence for ICP0-mediated depletion of either TRAF6 or IKKγ.
This would indicate that the role of ICP0 in TLR suppression is limited to facilitating USP7 nuclear export. In support of this, USP7 modified to express a nuclear export signal, USP7.NES (Figure 4 .A, panel IV) showed enhanced ability to suppress TLR2/6 cytokine response and was more effective at de-ubiquitinating IKKγ than native USP7, (Figure 7 .G, H). human DCs suppresses their APC function, the latter is dependent on TLR signaling 45 .
HSV mutants lacking ICP0 20 (d109 19 , in1312 46 and KM110 47 , n212 35 , 7134 35, 48 ) confirmed its role in suppressing interferon response. Subsequent work linked ICP0 to inhibition of IRF3/IRF7 33, 35 as a mechanism for suppression of interferon response. However, inhibition of IRF3/IRF7 is not sufficient to explain HSV ability to inhibit TLR2/TLR9-induced inflammatory cytokine response, the latter is mediated by MyD88-dependent NF-κB and MAPK activation, and is independent of IRF3/7.
On the other hand, several studies have linked HSV to induction of NF-κB activity in infected cells, the latter appears to be necessary for efficient viral replication [49] [50] [51] . This raises the question of how could HSV selectively promote sufficient NF-κB activity to promote its propagation yet avoid the robust innate cytokine response driven by the same NF-κB activity? This apparent contradiction is reconciled by the fact that HSV activates NF-κB through multiple signaling pathways. Some of which, such as HSV glycoprotein D activation of the TNF superfamily receptor HVEM (Hve-A) 52 drives both the canonical and alternative NF-κB pathway, the latter is resistant to ICP0 suppression.
TLR-mediated cytokine response, on the other hand, requires NF-κB and MAPK activity and both are 57 . A number of these processes impact pathogen life cycle, hence manipulation of the ubiquitin-proteasome system by pathogens has become a well-recognized survival strategy by viruses and bacteria 58, 59 . Stimulus-induced K63-ubiquitination of signaling adaptors following engagement of PRR, antigen receptors and cytokine receptors has been linked to NF-κB response 60 while its reversal by Cyld and A20 inhibits both NF-κB and MAPK response 61, 62 . Macrophages and DCs from mice with germline mutation expressing a ubiquitination-defective form of IKKγ (K392R) had blunted TLR cytokine response and were resistant to LPS-induced endotoxic shock 56 . Here, we present evidence that ICP0:USP7 complex protects HSV against host innate immunity by directing USP7 to disassemble K63-poly-ubiquitin chains off TRAF6 and IKKγ. Within the TLR signaling pathway, the auto-ubiquitination site for TRAF6 has been mapped to Lysine 124 55 while IKKγ is ubiquitinated at lysine 285 and 399 (392 in mouse) 63 . Both TRAF6 Lys124 and IKKγ Lys399 are within close proximity to at least one the USP7 consensus binding motifs, potentially enabling USP7 to dock in close proximity to poly-ubiquitinated lysine residues. Further supporting this hypothesis, the two P/AXXS USP7-binding motifs within IKKγ are located four residues from the binding site (aa 388-393) 64 of CYLD.
In summary, we show that HSV ICP0 is a potent inhibitor of TLR-mediated NF-κB response, an activity mediated through its partnership with the cellular DUB, USP7. ICP0 accomplishes this by only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From 21 translocating a nuclear protein, USP7 to the cytoplasm where it interacts with two adaptors within the TLR signaling pathway, TRAF6 and IKKγ. By translocating USP7 to the cytoplasm, ICP0 exploits USP7 normal response to TLR stimulation to the advantage of the HSV virus, effectively switching off TLR response to viral PAMPs. In support of this, a modified USP7 that constitutively resides in the cytosol was more effective than wt-USP7 at dampening TLR signal. The work shows how a seemingly contradictory set of functions residing on different domains of ICP0 (E3 ligase within the N-terminus RING domain and de-ubiquitinating activity of USP7 associated with the C-terminus of ICP0) could cooperate to provide comprehensive protection for HSV against the two main signaling pathways of innate immunity, namely IRF3/IRF7 mediated interferon response and NF-κB/MAPK mediated inflammatory cytokine response. Figure 7 only.
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